LIVINGSTON, N.J., May 14 /PRNewswire-FirstCall/ -- Milestone Scientific
Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced
injection technologies, today announced that it will be showcasing and
demonstrating its award winning STA(TM) System at the upcoming DPRWorld 08
(Dental Products Report) in Las Vegas, Nevada.
WHEN: Thursday, May 15 - Saturday, May 17, 2008
WHERE: Booth #262
3950 Las Vegas Blvd. SouthLas Vegas, Nevada 89119
WHO: Bob Presutti, Vice President of Sales & Marketing, Milestone
Other Sales Representatives from Milestone Scientific
WHAT: Demonstrations of the STA System
-- According to a December 2007 article published in Contemporary
Dental Assistant magazine, "The (STA) instrument is highly
effective in all areas of the oral cavity, including those
areas of dense connective tissue, such as the hard palate.
Dentists can provide traditional block anesthesia and
infiltration injections with this technology; however, special
techniques also may be employed to provide local anesthesia to
the precise teeth targeted for treatment via the periodontal
ligament (PDL) injection. The routine side effects of facial
and lingual numbness from a traditional anesthetic injection
soon may be a thing of the past."
-- Learn first hand how Milestone is redefining the standard of
care of the delivery of local anesthesia in dentistry.
-- Discover how the STA System is improving patient care and the
dental practice efficiency for those dentists who have adopted
CCLAD (Computer Controlled Local Anesthesia Delivery)
technology to more comfortably administer all dental
injections performed in their dental operatories.
NOTE TO PRESS: To arrange one-on-one interviews with Mr. Presutti, or to schedule a personal demonstration of the STA System, please contact John Morrison or Tiffany Korkis, Directors, Elite Media Group, at 407-585-1080 or via email at MLSS@efcg.net.
DPRWorld is a dynamic, completely new type of dental event -- a forum that enables forward-thinking dentists to reap the benefits of the latest industry advances in a setting that encourages communication and commerce. Uniquely focused on innovation, DPRWorld will deliver a sophisticated, interactive showcase of leading-edge products, equipment and technology, and world-class education. Here, in an environment created by America's leading dental publications, you will find everything you need to stay current and further develop your practice. A custom educational experience will empower you to become a better-educated consumer of the products and services you need to make your practice efficient and profitable.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(R) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA(TM) (Single Tooth Anesthesia) System computer- controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding the
timing and financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These statements
involve a number of risks and uncertainties and are based on assumptions
involving judgments with respect to future economic, competitive and market
conditions and future business decisions, all of which are difficult or
impossible to predict accurately and many of which are beyond Milestone's
control. Some of the important factors that could cause actual results to
differ materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected revenue
growth, changes in our operating expenses, adverse patent rulings, FDA or
legal developments, competitive pressures, changes in customer and market
requirements and standards, and the risk factors detailed from time to time
in Milestone's periodic filings with the Securities and Exchange
Commission, including without limitation, Milestone's Annual Report on Form
10-KSB for the year ended December 31, 2007. The forward looking-statements
in this press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or update
publicly any forward-looking statements for any reason.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group, LLC
Dodi Handy, President and CEO
407-585-1080 or via email at firstname.lastname@example.org
|SOURCE Milestone Scientific Inc.|
Copyright©2008 PR Newswire.
All rights reserved